MiR-145 Regulates the Chemoresistance of Hepatic Carcinoma Cells Against 5-Fluorouracil by Targeting Toll-Like Receptor 4 [Retraction]
Zheng RP, Ma DK, Li Z, Zhang HF. Cancer Manag Res. 2020;12:6165–6175. We, the Editors and Publisher of Cancer Management and Research, have retracted the following article. Since publication, concerns have been raised about the integrity of the data in the article. When approached for an...
Main Authors: | Zheng RP, Ma DK, Li Z, Zhang HF |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-09-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/retraction-mir-145-regulates-the-chemoresistance-of-hepatic-carcinoma--peer-reviewed-fulltext-article-CMAR |
Similar Items
-
MiR-145 Regulates the Chemoresistance of Hepatic Carcinoma Cells Against 5-Fluorouracil by Targeting Toll-Like Receptor 4
by: Zheng RP, et al.
Published: (2020-07-01) -
Potential Impact of Polymorphisms in Toll-like Receptors 2, 3, 4, 7, 9, miR-146a, miR-155, and miR-196a Genes on Osteoarthritis Susceptibility
by: Debora Stefik, et al.
Published: (2023-03-01) -
Scratching the Surface Takes a Toll: Immune Recognition of Viral Proteins by Surface Toll-like Receptors
by: Alexis A. Hatton, et al.
Published: (2022-12-01) -
Toll-like Receptors and Thrombopoiesis
by: Xiaoqin Tang, et al.
Published: (2023-01-01) -
Type I Interferon Dependent hsa-miR-145-5p Downregulation Modulates MUC1 and TLR4 Overexpression in Salivary Glands From Sjögren’s Syndrome Patients
by: Daniela Jara, et al.
Published: (2021-06-01)